| Metric | Count |
|---|---|
| Total Survey Responses (All Years) | 3625 |
| Statistic | DF | P_Value | |
|---|---|---|---|
| X-squared | 343 | 5 | < 1e-05 |
Conclusion - There is a significant difference in the number of survey responses between years. - The differences are not due to random variation. - Some years had much higher or much lower response counts than expected.
| Response | Count | Percent |
|---|---|---|
| No | 694 | 100 |
| Year | Response Bin | Count | Percentage (%) |
|---|---|---|---|
| 2024 | 0-9 | 144 | 13.2 |
| 2023 | 0-9 | 275 | 25.2 |
| 2022 | 0-9 | 270 | 24.7 |
| 2021 | 0-9 | 66 | 6.0 |
| 2020 | 0-9 | 157 | 14.4 |
| 2019 | 0-9 | 179 | 16.4 |
| 2024 | 10-19 | 17 | 9.4 |
| 2023 | 10-19 | 36 | 19.9 |
| 2022 | 10-19 | 37 | 20.4 |
| 2021 | 10-19 | 17 | 9.4 |
| 2020 | 10-19 | 36 | 19.9 |
| 2019 | 10-19 | 38 | 21.0 |
| 2024 | 20-29 | 7 | 6.4 |
| 2023 | 20-29 | 22 | 20.2 |
| 2022 | 20-29 | 32 | 29.4 |
| 2021 | 20-29 | 12 | 11.0 |
| 2020 | 20-29 | 20 | 18.3 |
| 2019 | 20-29 | 16 | 14.7 |
| 2024 | 30-39 | 8 | 10.1 |
| 2023 | 30-39 | 23 | 29.1 |
| 2022 | 30-39 | 15 | 19.0 |
| 2021 | 30-39 | 6 | 7.6 |
| 2020 | 30-39 | 7 | 8.9 |
| 2019 | 30-39 | 20 | 25.3 |
| 2024 | 40-49 | 4 | 6.9 |
| 2023 | 40-49 | 15 | 25.9 |
| 2022 | 40-49 | 15 | 25.9 |
| 2021 | 40-49 | 4 | 6.9 |
| 2020 | 40-49 | 11 | 19.0 |
| 2019 | 40-49 | 9 | 15.5 |
| 2024 | 50-59 | 6 | 12.5 |
| 2023 | 50-59 | 8 | 16.7 |
| 2022 | 50-59 | 11 | 22.9 |
| 2021 | 50-59 | 4 | 8.3 |
| 2020 | 50-59 | 13 | 27.1 |
| 2019 | 50-59 | 6 | 12.5 |
| 2024 | 60-69 | 2 | 6.5 |
| 2023 | 60-69 | 5 | 16.1 |
| 2022 | 60-69 | 11 | 35.5 |
| 2020 | 60-69 | 5 | 16.1 |
| 2019 | 60-69 | 8 | 25.8 |
| 2024 | 70-79 | 5 | 16.1 |
| 2023 | 70-79 | 12 | 38.7 |
| 2022 | 70-79 | 6 | 19.4 |
| 2021 | 70-79 | 1 | 3.2 |
| 2020 | 70-79 | 5 | 16.1 |
| 2019 | 70-79 | 2 | 6.5 |
| 2024 | 80-89 | 1 | 4.0 |
| 2023 | 80-89 | 4 | 16.0 |
| 2022 | 80-89 | 6 | 24.0 |
| 2021 | 80-89 | 3 | 12.0 |
| 2020 | 80-89 | 3 | 12.0 |
| 2019 | 80-89 | 8 | 32.0 |
| 2024 | 90-99 | 5 | 16.7 |
| 2023 | 90-99 | 9 | 30.0 |
| 2022 | 90-99 | 3 | 10.0 |
| 2021 | 90-99 | 3 | 10.0 |
| 2020 | 90-99 | 4 | 13.3 |
| 2019 | 90-99 | 6 | 20.0 |
| 2024 | NA | 7 | 15.6 |
| 2023 | NA | 13 | 28.9 |
| 2022 | NA | 5 | 11.1 |
| 2021 | NA | 4 | 8.9 |
| 2020 | NA | 7 | 15.6 |
| 2019 | NA | 9 | 20.0 |
| Response Bin | Count | Percentage (%) |
|---|---|---|
| <0.1 | 13 | 0.8 |
| 0.1-1.9 | 627 | 36.3 |
| 2.0-9.9 | 450 | 26.1 |
| >10 | 637 | 36.9 |
| Statistic | Value |
|---|---|
| Mean | 17.6238054212707 |
| Median | 3.145 |
| Mode | 0.1 |
| Standard Deviation | 54.1503354647716 |
| Range | 0 - 800 |
| Response Bin | Count | Percentage (%) |
|---|---|---|
| <0.1 | 33 | 2.1 |
| 0.1-1.9 | 615 | 38.9 |
| 2.0-9.9 | 437 | 27.6 |
| >10 | 497 | 31.4 |
| GENDER | Count | Percentage |
|---|---|---|
| FEMALE | 1986 | 81.8 |
| MALE | 442 | 18.2 |
n=
2428
| RACE | Count | Percentage |
|---|---|---|
| WHITE | 2288 | 95.89 |
| AMERICAN INDIAN OR ALASKA NATIVE | 48 | 2.01 |
| UNKNOWN | 23 | 0.96 |
| ASIAN | 10 | 0.42 |
| BLACK OR AFRICAN AMERICAN | 10 | 0.42 |
| NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 7 | 0.29 |
n=
2386
| ETHNICITY | Count | Percentage |
|---|---|---|
| NOT HISPANIC OR LATINO | 2216 | 93.74 |
| UNKNOWN | 101 | 4.27 |
| HISPANIC OR LATINO | 47 | 1.99 |
n=
2364
| EDUCATION | Count | Percentage |
|---|---|---|
| BACHELORS | 659 | 27.76 |
| SOME COLLEGE | 448 | 18.87 |
| MASTERS | 380 | 16.01 |
| ASSOCIATES | 260 | 10.95 |
| HIGHSCHOOL OR EQUIVALENT | 243 | 10.24 |
| TRADE/TECHNICAL/VOCATIONAL | 177 | 7.46 |
| DOCTORATE | 78 | 3.29 |
| PROFESSIONAL DEGREE | 71 | 2.99 |
| SOME HIGHSCHOOL | 58 | 2.44 |
n=
2374
| AGE_RANGE | Count | Percentage |
|---|---|---|
| 55-64 | 695 | 29.08 |
| 45-54 | 665 | 27.82 |
| 65+ | 423 | 17.70 |
| 35-44 | 393 | 16.44 |
| 25-34 | 158 | 6.61 |
| 18-24 | 56 | 2.34 |
n=
2390
| HOUSEHOLD_INCOME | Count | Percentage |
|---|---|---|
| BETWEEN $100,000 AND $150,000 | 473 | 22.13 |
| BETWEEN $50,000 AND $74,999 | 429 | 20.07 |
| BETWEEN $75,000 AND $99,999 | 364 | 17.03 |
| OVER $150,000 | 321 | 15.02 |
| BETWEEN $30,000 AND $49,999 | 295 | 13.80 |
| BETWEEN $15,000 AND $29,999 | 168 | 7.86 |
| UNDER $15,000 | 87 | 4.07 |
n=
2137
| Statistic | Value |
|---|---|
| Mean | 45.4 |
| Standard Deviation | 15.97 |
| Range | 0 - 85 |
| Age_Group | Count |
|---|---|
| 10-19 | 10 |
| 20-29 | 243 |
| 30-39 | 397 |
| 40-49 | 681 |
| 50-59 | 618 |
| 60-69 | 418 |
| 70-79 | 106 |
| 80-89 | 14 |
n
= 2487
| Statistic | Value |
|---|---|
| Mean | 49.81 |
| Standard Deviation | 13.79 |
| Range | 3 - 86 |
| Age | Count | Percentage (%) |
|---|---|---|
| 60 | 98 | 2.70 |
| 52 | 92 | 2.54 |
| 50 | 85 | 2.35 |
| 59 | 83 | 2.29 |
| 48 | 79 | 2.18 |
| 47 | 78 | 2.15 |
| 58 | 77 | 2.13 |
| 49 | 76 | 2.10 |
| 54 | 75 | 2.07 |
| 57 | 75 | 2.07 |
| 46 | 74 | 2.04 |
| 55 | 74 | 2.04 |
| 45 | 73 | 2.01 |
| 63 | 70 | 1.93 |
| 65 | 68 | 1.88 |
| 42 | 67 | 1.85 |
| 62 | 67 | 1.85 |
| 53 | 66 | 1.82 |
| 51 | 65 | 1.79 |
| 43 | 64 | 1.77 |
| 56 | 64 | 1.77 |
| 40 | 62 | 1.71 |
| 44 | 61 | 1.68 |
| 38 | 52 | 1.44 |
| 61 | 52 | 1.44 |
| 64 | 51 | 1.41 |
| 39 | 50 | 1.38 |
| 41 | 50 | 1.38 |
| 36 | 46 | 1.27 |
| 66 | 43 | 1.19 |
| 69 | 43 | 1.19 |
| 37 | 40 | 1.10 |
| 35 | 38 | 1.05 |
| 67 | 36 | 0.99 |
| 70 | 31 | 0.86 |
| 71 | 30 | 0.83 |
| 34 | 28 | 0.77 |
| 68 | 28 | 0.77 |
| 29 | 25 | 0.69 |
| 27 | 23 | 0.63 |
| 32 | 23 | 0.63 |
| 72 | 23 | 0.63 |
| 30 | 20 | 0.55 |
| 33 | 20 | 0.55 |
| 25 | 18 | 0.50 |
| 28 | 18 | 0.50 |
| 31 | 17 | 0.47 |
| 24 | 15 | 0.41 |
| 74 | 15 | 0.41 |
| 21 | 12 | 0.33 |
| 26 | 12 | 0.33 |
| 73 | 12 | 0.33 |
| 23 | 11 | 0.30 |
| 75 | 11 | 0.30 |
| 22 | 10 | 0.28 |
| 19 | 7 | 0.19 |
| 20 | 6 | 0.17 |
| 76 | 6 | 0.17 |
| 77 | 6 | 0.17 |
| 80 | 4 | 0.11 |
| 83 | 4 | 0.11 |
| 79 | 3 | 0.08 |
| 78 | 2 | 0.06 |
| 81 | 2 | 0.06 |
| 82 | 2 | 0.06 |
| 85 | 2 | 0.06 |
| 86 | 1 | 0.03 |
n
= 2641
| Additional Tickborne Diagnosis | Count | Percentage |
|---|---|---|
| NONE | 2108 | 75.12 |
| LYME (BORRELIA BURGDORFERI) | 335 | 11.94 |
| RICKETTSIAS AND/OR ROCKY MOUNTAIN SPOTTED FEVER | 215 | 7.66 |
| EHRLICHIOSIS | 60 | 2.14 |
| BABESIA | 47 | 1.67 |
| STARI (SOUTHERN TICK-ASSOCIATED RASH ILLNESS) | 25 | 0.89 |
| ANAPLASMOSIS | 5 | 0.18 |
| HEARTLAND VIRUS | 5 | 0.18 |
| BORRELIA MAYONNI | 3 | 0.11 |
| BORRELIA MIYAMOTOI | 3 | 0.11 |
n
= 2375
| Type of Healthcare Provider Diagnosis | Count | Percentage |
|---|---|---|
| ALLERGIST | 1289 | 53.73 |
| PRIMARY CARE PROVIDER (MD OR DO) | 737 | 30.72 |
| NURSE PRACTITIONER | 158 | 6.59 |
| GASTROENTEROLOGIST | 112 | 4.67 |
| IMMUNOLOGIST | 46 | 1.92 |
| PHYSICIAN ASSISTANT | 40 | 1.67 |
| OBSTETRICIAN/GYNECOLOGIST | 5 | 0.21 |
| CARDIOLOGIST | 3 | 0.13 |
| DENTIST | 3 | 0.13 |
| ENDOCRINOLOGIST | 3 | 0.13 |
| PEDIATRICIAN | 3 | 0.13 |
n
= 2473
| Mammal Ingredient Reaction | Count | Percentage |
|---|---|---|
| BEEF | 2545 | 97.73 |
| PORK | 2276 | 87.40 |
| DAIRY | 1743 | 66.94 |
| GELATIN (FOOD OR MEDICINE E.G. GEL CAPS) | 1599 | 61.41 |
| PERSONAL CARE PRODUCTS (E.G. TAMPONS, COSMETICS, SHAMPOO, LOTIONS) | 1104 | 42.40 |
| PRESCRIPTION MEDICATIONS | 1075 | 41.28 |
| OVER-THE-COUNTER MEDICATIONS | 956 | 36.71 |
| LAMB | 889 | 34.14 |
| HOUSEHOLD PRODUCTS (E.G. CLEANING PRODUCTS, LAUNDRY DETERGENT, OR DRYER SHEETS) | 856 | 32.87 |
| VENISON | 801 | 30.76 |
| VACCINATIONS | 402 | 15.44 |
| DENTAL/SURGICAL MEDICAL SUPPLIES | 344 | 13.21 |
| TEXTILES | 333 | 12.79 |
n
= 2683
| Number of Reactions Prior to Diagnosis | Count | Percentage |
|---|---|---|
| 15 OR MORE | 1060 | 42.55 |
| 10 to 14 | 132 | 5.30 |
| 5 to 9 | 324 | 13.01 |
| 1 to 4 | 646 | 25.93 |
| None | 329 | 13.21 |
n
= 2567
| Medical Intervention | Count | Percentage (%) |
|---|---|---|
| NONE OF THE ABOVE | 1986 | 54.82 |
| VISITED THE EMERGENCY ROOM | 979 | 27.02 |
| VISITED AN URGENT CARE FACILITY | 270 | 7.45 |
| SELF-ADMINISTERED AN EPI-PEN | 164 | 4.53 |
| ADMITTED TO THE HOSPITAL | 163 | 4.50 |
| ADMITTED TO THE INTENSIVE CARE UNIT (ICU) | 61 | 1.68 |
n
= 3623
| Additional Allergy | Count | Percentage (%) |
|---|---|---|
| NONE OF THE ABOVE | 2240 | 61.83 |
| MEATS | 875 | 24.15 |
| DAIRY (COW/SHEEP/GOAT MILK, CHEESE, YOGURT, ETC.) | 754 | 20.81 |
| WHEAT (GLUTEN) | 291 | 8.03 |
| CARAGEENAN | 282 | 7.78 |
| SHELLFISH | 202 | 5.58 |
| EGG | 190 | 5.24 |
| PEANUT | 170 | 4.69 |
| TREE NUTS | 169 | 4.66 |
| SOY | 122 | 3.37 |
| FRUITS | 121 | 3.34 |
| SESAME/SESAME SEEDS | 92 | 2.54 |
| VEGETABLES | 90 | 2.48 |
| CEREALS & GRAINS | 77 | 2.13 |
| BEANS, LEGUMES, PULSES | 67 | 1.85 |
| FINNED FISH | 44 | 1.21 |
n
= 3623
| Exposure | Count | Percentage (%) |
|---|---|---|
| HOME | 2339 | 64.56 |
| RESTAURANT/EATING OUT | 2020 | 55.75 |
| WORK | 1049 | 28.95 |
| NONE OF THE ABOVE | 956 | 26.39 |
| SCHOOL | 165 | 4.55 |
| COLLEGE | 100 | 2.76 |
| DAYCARE | 9 | 0.25 |
n
= 3623
| Post-Exposure Time | Count | Percentage (%) |
|---|---|---|
| 4-6 HOURS | 1349 | 49.60 |
| 6-8 HOURS | 787 | 28.93 |
| 3 HOURS (180-239 MINUTES) | 714 | 26.25 |
| 1 TO 2 HOURS (61-120 MINUTES) | 597 | 21.95 |
| 2 HOURS (120-179 MINUTES) | 494 | 18.16 |
| 6 TO 30 MINUTES | 490 | 18.01 |
| 8 HOURS OR MORE | 452 | 16.62 |
| 31 TO 60 MINUTES | 417 | 15.33 |
| 0 TO 5 MINUTES | 347 | 12.76 |
| UNSURE | 164 | 6.03 |
n
= 3623
| Other Family Members Diagnosed with AGS | Count | Percentage (%) |
|---|---|---|
| NO | 2167 | 79.67 |
| NOT SURE | 145 | 5.33 |
| CHILD | 50 | 1.84 |
| SPOUSE | 46 | 1.69 |
| MOTHER | 40 | 1.47 |
| DAUGHTER | 28 | 1.03 |
| BROTHER | 27 | 0.99 |
| HUSBAND | 26 | 0.96 |
| SISTER | 23 | 0.85 |
| SON | 21 | 0.77 |
| FATHER | 16 | 0.59 |
| COUSIN | 13 | 0.48 |
| NEPHEW | 11 | 0.40 |
| SIBLING | 11 | 0.40 |
| AUNT | 10 | 0.37 |
| NIECE | 8 | 0.29 |
| BROTHER IN LAW | 7 | 0.26 |
| WIFE | 7 | 0.26 |
| GRANDDAUGHTER | 6 | 0.22 |
| UNCLE | 6 | 0.22 |
| 3 CHILDREN | 5 | 0.18 |
| FATHER IN LAW | 5 | 0.18 |
| MOM | 5 | 0.18 |
| COUSINS | 4 | 0.15 |
| MY HUSBAND | 4 | 0.15 |
| SISTER IN LAW | 4 | 0.15 |
| 2 DAUGHTERS | 3 | 0.11 |
| DAUGHTER IN LAW | 3 | 0.11 |
| GRANDSON | 3 | 0.11 |
| ADULT CHILD | 2 | 0.07 |
| DAD | 2 | 0.07 |
| GRANDCHILD | 2 | 0.07 |
| MOTHER AND SISTER IN LAW | 2 | 0.07 |
| MY NIECE | 2 | 0.07 |
| MY SISTER | 2 | 0.07 |
| NEICE | 2 | 0.07 |
| STEP FATHER | 2 | 0.07 |
| STEP SISTER | 2 | 0.07 |
| TWO DAUGHTERS | 2 | 0.07 |
| 2 CHILDREN | 1 | 0.04 |
| 2 SIBLINGS | 1 | 0.04 |
| 3 COUSINS | 1 | 0.04 |
| 3RD COUSIN | 1 | 0.04 |
| A COUSIN | 1 | 0.04 |
| ADOPTED BROTHER (NOT GENETICALLY RELATED) | 1 | 0.04 |
| AND MY SISTER WHO IS 54 | 1 | 0.04 |
| AND NOW HE HAS NO PROBLEM. | 1 | 0.04 |
| AND POSSIBLY FATHER | 1 | 0.04 |
| AND SISTER | 1 | 0.04 |
| BUT MY LIVE-IN GIRLFRIENDS OLDEST SISTER WHO IS NOW 70 | 1 | 0.04 |
| BUT RECENTLY FOUND OUT SHE CAN EAT BEEF AGAIN. | 1 | 0.04 |
| CHILD (DAUGHTER) | 1 | 0.04 |
| DAD AND MOM BOTH GOT DIAGNOSED AFTER ME | 1 | 0.04 |
| DAUGHTER & SPOUSE | 1 | 0.04 |
| DAUGHTER-IN-LAW | 1 | 0.04 |
| DIFFERENT HOUSEHOLD | 1 | 0.04 |
| FIRST COUSIN | 1 | 0.04 |
| GRAND DAUGHTER | 1 | 0.04 |
| GRANDCHILDREN | 1 | 0.04 |
| GRANDMOTHER | 1 | 0.04 |
| GRANDSONS | 1 | 0.04 |
| GREAT AUNT | 1 | 0.04 |
| GREAT NEPHEW | 1 | 0.04 |
| GREAT UNCLE | 1 | 0.04 |
| HUSBAND AND TWO ADULT CHILDREN ARE AG POSTIVE | 1 | 0.04 |
| HUSBAND IS NOW BEING TESTED | 1 | 0.04 |
| I BELIEVE SPOUSE HAS BUT NOT TESTED | 1 | 0.04 |
| I HAVE A COUSIN WHO MIGHT HAVE IT | 1 | 0.04 |
| I HAVE IDENTICAL TWIN BOYS BOTH HAVE IT AS WELL. ONE HAS VERY HIGH NUMBERS AND ONE HAS LOW | 1 | 0.04 |
| INLAWS | 1 | 0.04 |
| ITS ODD AS THEY ARE IDENTICAL. | 1 | 0.04 |
| KIDS | 1 | 0.04 |
| MATERNAL COUSINS | 1 | 0.04 |
| MAYBE SON | 1 | 0.04 |
| ME | 1 | 0.04 |
| MOM WHO LIVES NEXT DOOR | 1 | 0.04 |
| MOTHER | 1 | 0.04 |
| MOTHER AND MAYBE OTHER FAMILY MEMBERS | 1 | 0.04 |
| MOTHER AND DAUGHTER | 1 | 0.04 |
| MOTHER AND MATERNAL GRANDFATHER | 1 | 0.04 |
| MOTHER AND SISTER | 1 | 0.04 |
| MOTHER AND SISTERS | 1 | 0.04 |
| MOTHER AND TWO SONS | 1 | 0.04 |
| MOTHER I CARE FOR | 1 | 0.04 |
| MOTHER IN LAW AND GRANDMOTHER IN LAW | 1 | 0.04 |
| MOTHER IN-LAW | 1 | 0.04 |
| MOTHER-IN-LAW | 1 | 0.04 |
| MY 12 YEAR OLD SON WAS DIAGNOSED RIGHT AFTER ME | 1 | 0.04 |
| MY 9 YEAR OLD DAUGHTER | 1 | 0.04 |
| MY BROTHER WHO IS 58 | 1 | 0.04 |
| MY CHILD | 1 | 0.04 |
| MY COUSINS DAUGHTER HAS AGS | 1 | 0.04 |
| MY DAUGHTER HAD IT FOR 8 YEARS | 1 | 0.04 |
| MY HALF-SISTER ON MY FATHERS SIDE | 1 | 0.04 |
| MY HUSBAND’S UNCLE HAS ALSO BEEN DIAGNOSED. (NOT A BLOOD RELATIVE TO ME) | 1 | 0.04 |
| MY MOTHER AND MY NIECE | 1 | 0.04 |
| MY NEPHEW | 1 | 0.04 |
| MY OLDEST SON WAS DIAGNOSED DECEMBER 2019 | 1 | 0.04 |
| MY SON | 1 | 0.04 |
| MY SON HAD IT 8 YEARS | 1 | 0.04 |
| MY SPOUSE IS CURRENTLY BEING TESTED. WE HIGHLY SUSPECT HIS RESULTS WILL BE POSITIVE. | 1 | 0.04 |
| NEPHEW IN MONTANA | 1 | 0.04 |
| NIECE NIRVE GREAT NIECE NEPHEW GREAT NEPHEW | 1 | 0.04 |
| NIECE THAT DOES NOT LIVE WITH US | 1 | 0.04 |
| NINE CHILDREN | 1 | 0.04 |
| NOT FAMILY | 1 | 0.04 |
| NOT RELATED | 1 | 0.04 |
| OLDEST SON | 1 | 0.04 |
| PARENT | 1 | 0.04 |
| PATERNAL AUNT | 1 | 0.04 |
| RECENTLY DIAGNOSED. | 1 | 0.04 |
| SAME TOWN | 1 | 0.04 |
| SIBKING | 1 | 0.04 |
| SIBLING. BROTHER | 1 | 0.04 |
| SISTER 73 | 1 | 0.04 |
| SISTER AND NIECE | 1 | 0.04 |
| SISTER-IN-LAW | 1 | 0.04 |
| SISTERINLAW | 1 | 0.04 |
| SISTERS-IN-LAW | 1 | 0.04 |
| SON | 1 | 0.04 |
| SPOUSE AND CHILD | 1 | 0.04 |
| SPOUSE. DAUGHTER. | 1 | 0.04 |
| SPOUSE; HE HAS GI SYMPTOMS | 1 | 0.04 |
| STEP-BROTHER | 1 | 0.04 |
| STEPSON | 1 | 0.04 |
| TWO OF MY CHILDREN | 1 | 0.04 |
n
= 2720
| AGS Symptoms | Count | Percentage (%) |
|---|---|---|
| GASTROINTESTINAL | 2347 | 86.29 |
| SKIN | 2274 | 83.60 |
| RESPIRATORY | 1631 | 59.96 |
| CARDIOVASCULAR | 1131 | 41.58 |
| EMOTIONAL | 1047 | 38.49 |
| MOTOR (MUSCLES) | 651 | 23.93 |
| NERVOUS SYSTEM (REFLEXES) | 626 | 23.01 |
| NOT SURE | 74 | 2.72 |
| 3 | 0.11 |
n
= 2717
| YEAR | AGS_SYMPTOMS | Count | Total | Percentage |
|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 398 | 2347 | 17.0 |
| 2020 | GASTROINTESTINAL | 397 | 2347 | 16.9 |
| 2021 | GASTROINTESTINAL | 190 | 2347 | 8.1 |
| 2022 | GASTROINTESTINAL | 540 | 2347 | 23.0 |
| 2023 | GASTROINTESTINAL | 548 | 2347 | 23.3 |
| 2024 | GASTROINTESTINAL | 274 | 2347 | 11.7 |
| 2019 | SKIN | 417 | 2274 | 18.3 |
| 2020 | SKIN | 428 | 2274 | 18.8 |
| 2021 | SKIN | 209 | 2274 | 9.2 |
| 2022 | SKIN | 527 | 2274 | 23.2 |
| 2023 | SKIN | 519 | 2274 | 22.8 |
| 2024 | SKIN | 174 | 2274 | 7.7 |
| 2019 | RESPIRATORY | 300 | 1631 | 18.4 |
| 2020 | RESPIRATORY | 321 | 1631 | 19.7 |
| 2021 | RESPIRATORY | 152 | 1631 | 9.3 |
| 2022 | RESPIRATORY | 354 | 1631 | 21.7 |
| 2023 | RESPIRATORY | 381 | 1631 | 23.4 |
| 2024 | RESPIRATORY | 123 | 1631 | 7.5 |
| 2019 | CARDIOVASCULAR | 185 | 1131 | 16.4 |
| 2020 | CARDIOVASCULAR | 211 | 1131 | 18.7 |
| 2021 | CARDIOVASCULAR | 100 | 1131 | 8.8 |
| 2022 | CARDIOVASCULAR | 254 | 1131 | 22.5 |
| 2023 | CARDIOVASCULAR | 285 | 1131 | 25.2 |
| 2024 | CARDIOVASCULAR | 96 | 1131 | 8.5 |
| 2019 | EMOTIONAL | 181 | 1047 | 17.3 |
| 2020 | EMOTIONAL | 170 | 1047 | 16.2 |
| 2021 | EMOTIONAL | 76 | 1047 | 7.3 |
| 2022 | EMOTIONAL | 249 | 1047 | 23.8 |
| 2023 | EMOTIONAL | 278 | 1047 | 26.6 |
| 2024 | EMOTIONAL | 93 | 1047 | 8.9 |
| 2019 | MOTOR (MUSCLES) | 108 | 651 | 16.6 |
| 2020 | MOTOR (MUSCLES) | 114 | 651 | 17.5 |
| 2021 | MOTOR (MUSCLES) | 52 | 651 | 8.0 |
| 2022 | MOTOR (MUSCLES) | 147 | 651 | 22.6 |
| 2023 | MOTOR (MUSCLES) | 170 | 651 | 26.1 |
| 2024 | MOTOR (MUSCLES) | 60 | 651 | 9.2 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 110 | 626 | 17.6 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 116 | 626 | 18.5 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 47 | 626 | 7.5 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 130 | 626 | 20.8 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 165 | 626 | 26.4 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 58 | 626 | 9.3 |
| 2019 | NOT SURE | 13 | 74 | 17.6 |
| 2020 | NOT SURE | 21 | 74 | 28.4 |
| 2021 | NOT SURE | 4 | 74 | 5.4 |
| 2022 | NOT SURE | 11 | 74 | 14.9 |
| 2023 | NOT SURE | 18 | 74 | 24.3 |
| 2024 | NOT SURE | 7 | 74 | 9.5 |
| Skin-Related Issues | Count | Percentage (%) |
|---|---|---|
| ITCHING | 2184 | 80.29 |
| HIVES (WELTS, URTICARIA) | 1931 | 70.99 |
| FLUSHING | 1567 | 57.61 |
| RASH (REDNESS OF SKIN) | 1564 | 57.50 |
| SWELLING (ANGIOEDEMA) | 1228 | 45.15 |
| HOT FLASH, HOT SKIN | 1221 | 44.89 |
| RED, ITCHY OR WATERY EYES | 1082 | 39.78 |
| NONE | 157 | 5.77 |
| UNSURE | 41 | 1.51 |
| 25 | 0.92 |
| Skin-Related Issues | Count | Percentage (%) |
|---|---|---|
| ITCHING | 2184 | 80.29 |
| HIVES (WELTS, URTICARIA) | 1931 | 70.99 |
| FLUSHING | 1567 | 57.61 |
| RASH (REDNESS OF SKIN) | 1564 | 57.50 |
| SWELLING (ANGIOEDEMA) | 1228 | 45.15 |
| HOT FLASH, HOT SKIN | 1221 | 44.89 |
| RED, ITCHY OR WATERY EYES | 1082 | 39.78 |
| NONE | 157 | 5.77 |
| UNSURE | 41 | 1.51 |
| Respiratory Issues | Count | Percentage (%) |
|---|---|---|
| NASAL CONGESTION/STUFFY OR RUNNY NOSE | 1384 | 50.88 |
| TROUBLE BREATHING (SHORTNESS OF BREATH) | 1264 | 46.47 |
| CHEST TIGHTENING | 1192 | 43.82 |
| COUGHING | 1188 | 43.68 |
| ANAPHYLAXIS | 952 | 35.00 |
| HOARSE VOICE | 931 | 34.23 |
| WHEEZING | 764 | 28.09 |
| SNEEZING | 679 | 24.96 |
| CHEST PAIN | 588 | 21.62 |
| NONE | 372 | 13.68 |
| UNSURE | 137 | 5.04 |
| 36 | 1.32 |
n
= 9487
| Gastrointestinal Issues | Count | Percentage (%) |
|---|---|---|
| DIARRHEA | 1995 | 73.35 |
| STOMACH PAIN/CRAMPS | 1967 | 72.32 |
| BLOATING | 1593 | 58.57 |
| NAUSEA | 1562 | 57.43 |
| ITCHY THROAT/EAR CANAL | 1214 | 44.63 |
| VOMITING | 967 | 35.55 |
| REFLUX | 949 | 34.89 |
| TONGUE SWELLING/THROAT TIGHTNESS | 927 | 34.08 |
| DIFFICULTY SWALLOWING | 745 | 27.39 |
| TINGLING MOUTH | 733 | 26.95 |
| CONSTIPATION | 676 | 24.85 |
| ODD TASTE IN MOUTH/METALLIC TASTE | 572 | 21.03 |
| BLOODY STOOLS | 173 | 6.36 |
| NONE | 108 | 3.97 |
| UNSURE | 53 | 1.95 |
| 19 | 0.70 |
n
= 14253
[1] 150
| Symptom | Count |
|---|---|
| GASTROINTESTINAL | 150 |
| Cardiovascular Issues | Count | Percentage (%) |
|---|---|---|
| LIGHTHEADEDNESS/DIZZINESS | 1408 | 51.76 |
| RAPID HEARTBEAT (TACHYCARDIA) | 1079 | 39.67 |
| LOW BLOOD PRESSURE | 789 | 29.01 |
| IRREGULAR HEART RATE | 753 | 27.68 |
| CHEST PAIN | 529 | 19.45 |
| NONE | 504 | 18.53 |
| A WEAK PULSE | 293 | 10.77 |
| UNSURE | 288 | 10.59 |
| SLOW HEARTBEAT (BRADYCARDIA) | 176 | 6.47 |
| TURNING BLUE | 66 | 2.43 |
| 45 | 1.65 | |
| CARDIAC ARREST | 24 | 0.88 |
n
= 5954
| Emotional/Behavioral Issues | Count | Percentage (%) |
|---|---|---|
| ANXIETY | 1780 | 65.44 |
| FATIGUE | 1558 | 57.28 |
| SLEEP DISTURBANCES | 1192 | 43.82 |
| HEADACHE/MIGRAINES | 1110 | 40.81 |
| WITHDRAWAL FROM SOCIAL AND RECREATIONAL ACTIVITIES | 1050 | 38.60 |
| IRRITABILITY | 1033 | 37.98 |
| FEELING OF “IMPENDING DOOM” | 923 | 33.93 |
| MEMORY RECALL | 876 | 32.21 |
| DEPRESSION | 868 | 31.91 |
| PANIC | 839 | 30.85 |
| CONFUSION | 760 | 27.94 |
| NONE | 239 | 8.79 |
| UNSURE | 116 | 4.26 |
| 19 | 0.70 |
n
= 12363
| Nervous System Issues | Count | Percentage (%) |
|---|---|---|
| ABNORMAL SWEATING | 814 | 29.93 |
| DRY SKIN | 625 | 22.98 |
| NONE | 587 | 21.58 |
| DEHYDRATION | 586 | 21.54 |
| WEIGHT GAIN | 552 | 20.29 |
| WEIGHT LOSS | 467 | 17.17 |
| FAINTING OR LOSS OF CONSCIOUSNESS | 456 | 16.76 |
| UNSURE | 410 | 15.07 |
| URINARY DYSFUNCTION | 278 | 10.22 |
| SEXUAL DYSFUNCTION | 224 | 8.24 |
| UTERINE CONTRACTIONS | 109 | 4.01 |
| 92 | 3.38 |
n
= 5200
| Motor Issues | Count | Percentage (%) |
|---|---|---|
| NONE | 958 | 35.22 |
| MUSCLE CRAMPING | 944 | 34.71 |
| LEG WEAKNESS | 624 | 22.94 |
| ARM WEAKNESS | 560 | 20.59 |
| NOT SURE | 440 | 16.18 |
| MUSCLE WASTING | 186 | 6.84 |
| CLAWING OF TOES | 167 | 6.14 |
| 130 | 4.78 |
n
= 4009
| Comorbid Diagnosis | Count | Percentage (%) |
|---|---|---|
| VITAMIN D DEFICIENCY | 976 | 35.88 |
| ALLERGIC RHINITIS (HAY FEVER) | 975 | 35.85 |
| HEARTBURN (ACID REFLUX) | 950 | 34.93 |
| DRUG ALLERGY | 828 | 30.44 |
| HIGH BLOOD PRESSURE (HYPERTENSION) | 820 | 30.15 |
| ANAPHYLAXIS | 723 | 26.58 |
| ASTHMA | 657 | 24.15 |
| MIGRAINE HEADACHES | 624 | 22.94 |
| IRRITABLE BOWEL SYNDROME | 545 | 20.04 |
| THYROID DISEASE | 423 | 15.55 |
| OSTEOARTHRITIS | 410 | 15.07 |
| HYPERTENSION | 364 | 13.38 |
| BEE STING ALLERGY | 363 | 13.35 |
| LACTOSE INTOLERANCE | 346 | 12.72 |
| CONTACT DERMATITIS | 333 | 12.24 |
| ATOPIC DERMATITIS (ECZEMA) | 323 | 11.88 |
| MENTAL HEALTH DISORDER | 320 | 11.76 |
| GLUTEN SENSITIVITY | 291 | 10.70 |
| LATEX ALLERGY | 287 | 10.55 |
| TYPE 2 DIABETES | 243 | 8.93 |
| NONE | 206 | 7.57 |
| ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) | 199 | 7.32 |
| CANCER | 197 | 7.24 |
| MAST CELL DISEASE | 196 | 7.21 |
| ARRHYTHMIAS | 182 | 6.69 |
| RHEUMATOID ARTHRITIS | 128 | 4.71 |
| HEART DISEASE | 108 | 3.97 |
| ORAL ALLERGY SYNDROME (OAS)/POLLEN-FOOD SYNDROME | 94 | 3.46 |
| CONNECTIVE TISSUE DISORDER | 87 | 3.20 |
| HEART DEFECTS | 75 | 2.76 |
| INFLAMMATORY BOWEL DISEASE (CROHN’S DISEASE/ULCERATIVE COLITIS) | 59 | 2.17 |
| CELIAC DISEASE | 50 | 1.84 |
| STROKE | 50 | 1.84 |
| EOSINOPHILIC ESOPHAGITIS | 38 | 1.40 |
| UNSURE | 35 | 1.29 |
| HISTAMINE TOXICITY (SCOMBROID POISONING) | 23 | 0.85 |
| 17 | 0.62 | |
| HYPER-IGE SYNDROME (HIE) | 17 | 0.62 |
| AUTISM | 12 | 0.44 |
| FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME (FPIES) | 12 | 0.44 |
| TYPE 1 DIABETES | 11 | 0.40 |
n
= 12597
| Outgrown or Tolerant to Mammalian Ingredients | Count | Percentage (%) |
|---|---|---|
| NO | 1949 | 71.65 |
| UNSURE | 579 | 21.29 |
| YES | 192 | 7.06 |
n
= 2720
| Question | N Total | N Answered | Response Rate |
|---|---|---|---|
| Please provide any additional input, comments, opinions, or suggestions below. Please feel free to share advice or feedback for healthcare providers, other AGS patients, or other affected individuals. | 3625 | 1742 | 48.1% |
| Besides avoidance of mammalian ingredients, are there other therapies or interventions you have discovered that help reduce the severity and frequency of Alpha-gal reactions or symptoms? Please Explain. | 3625 | 2303 | 63.5% |
| Ethnicity: | 3625 | 2365 | 65.2% |
| Education: | 3625 | 2375 | 65.5% |
| Have you ever been diagnosed with any of the following tick-borne conditions? Please check all that apply. | 3625 | 2376 | 65.5% |
| PREVENTION_METHOD | 3625 | 2386 | 65.8% |
| Race (Select all that apply): | 3625 | 2387 | 65.8% |
| Household Income: | 3625 | 2390 | 65.9% |
| When was your MOST RECENT AGS blood test performed and what was your Alpha-gal IgE value? | 3625 | 2405 | 66.3% |
| Zip Code: | 3625 | 2408 | 66.4% |
| Gender: | 3625 | 2429 | 67.0% |
| Age Range: | 3625 | 2434 | 67.1% |
| This concludes our survey. THANK YOU for your participation. Do you want to be contacted by TBC United with information about future clinical trials or research studies?: | 3625 | 2441 | 67.3% |
| MENTAL_HEALTH_CONCERNS | 3625 | 2461 | 67.9% |
| What, if any, financial impacts (positive or negative) have you experienced due to Alpha-gal Syndrome? | 3625 | 2466 | 68.0% |
| What type of doctor or healthcare provider first made the Alpha-gal syndrome diagnosis? | 3625 | 2474 | 68.2% |
| What, if any, social impacts (positive or negative) have you experienced due to Alpha-gal Syndrome (e.g. ability to go out, spend time with family and friends, etc)? | 3625 | 2522 | 69.6% |
| Has the participant ever been diagnosed by a doctor as allergic to any of the following foods or food groups? (Check all that apply.) | 3625 | 2588 | 71.4% |
| Choose the MOTOR (muscle) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3625 | 2591 | 71.5% |
| Choose the NERVOUS SYSTEM (reflexes) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3625 | 2629 | 72.5% |
| Do you currently use products that have been genetically modified? | 3625 | 2634 | 72.7% |
| Indicate your willingness to consume a food product such as steak, bacon, or lamb that is a product of animal biotechnology. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use OVER-THE-COUNTER MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use PRESCRIPTION MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use VACCINATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use FOOD PRODUCTS such as steak, bacon, or lamb that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use PERSONAL CARE PRODUCTS such as shampoo or cosmetics with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| Indicate your willingness to use HOUSEHOLD PRODUCTS such as cleaning products or laundry detergent with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 72.7% |
| ACCESS_INFORMATION | 3625 | 2658 | 73.3% |
| Where have you had exposures that caused reactions to occur? Check all that apply. | 3625 | 2668 | 73.6% |
| When was your FIRST AGS blood test performed and what was your Alpha-gal IgE value? | 3625 | 2668 | 73.6% |
| Choose the CARDIOVASCULAR (heart) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2676 | 73.8% |
| At what age did you first begin experiencing allergic reactions (e.g. eczema, hives, itching) to mammalian ingredients? | 3625 | 2679 | 73.9% |
| What mammalian ingredients/items have you reacted to? Check all that apply. | 3625 | 2684 | 74.0% |
| Choose the RESPIRATORY (lungs/breathing) symptoms you experience from a reaction to mammalian ingredients (Select all that apply.) | 3625 | 2685 | 74.1% |
| How easy is it to identify Alpha-gal free vaccines? | 3625 | 2692 | 74.3% |
| How easy is it to identify Alpha-gal free prescription medications? | 3625 | 2694 | 74.3% |
| How easy is it to identify Alpha-gal free household items? Examples include cleaning products, laundry detergent, and dryer sheets. | 3625 | 2694 | 74.3% |
| How easy is it to identify Alpha-gal free personal care products? Examples include shampoo, cosmetics, and soap. | 3625 | 2695 | 74.3% |
| Choose the SKIN symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2696 | 74.4% |
| How easy is it to identify Alpha-gal free over-the-counter medications? | 3625 | 2696 | 74.4% |
| Would you use an Alpha-gal free valve replacement that was from a pig or other mammal that has been genetically modified? | 3625 | 2697 | 74.4% |
| Choose the GASTROINTESTINAL (digestive tract) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2702 | 74.5% |
| Choose the EMOTIONAL/BEHAVIORAL symptoms you experience due to the Alpha-gal Syndrome diagnosis (Select all that apply.) | 3625 | 2702 | 74.5% |
| COMORBID_DIAGNOSIS | 3625 | 2704 | 74.6% |
| How many reactions did you experience prior to diagnosis? | 3625 | 2707 | 74.7% |
| How easy is it to identify Alpha-gal free food products? (Likeart scale 1-10) | 3625 | 2712 | 74.8% |
| If you needed a heart valve replacement and it were available, would you ask your healthcare provider to use an Alpha-gal free heart valve? | 3625 | 2714 | 74.9% |
| Would you eat Alpha-gal free pork, beef, or lamb? | 3625 | 2715 | 74.9% |
| What type of symptoms do you have? (Select all that apply.) | 3625 | 2718 | 75.0% |
| Do you remember being bitten by a tick prior to symptoms of Alpha-gal Syndrome? | 3625 | 2721 | 75.1% |
| At what age were you diagnosed with Alpha-gal Syndrome? | 3625 | 2721 | 75.1% |
| Before you developed Alpha-gal Syndrome, what was your primary dietary preference? Please select the best option. | 3625 | 2721 | 75.1% |
| Since your Alpha-gal Syndrome diagnosis, how many reactions do you have per year? | 3625 | 2721 | 75.1% |
| Which of the following medical interventions have you experienced because of Alpha-gal Syndrome? | 3625 | 2721 | 75.1% |
| How soon after exposure to mammalian ingredients do your reactions occur? Check all that apply. | 3625 | 2721 | 75.1% |
| Do you have other family members diagnosed with AGS? | 3625 | 2721 | 75.1% |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 3625 | 2721 | 75.1% |
| You are invited to participate | 3625 | 3604 | 99.4% |
| Respondent ID | 3625 | 3624 | 100.0% |
| Collector ID | 3625 | 3624 | 100.0% |
| Start Date | 3625 | 3624 | 100.0% |
| End Date | 3625 | 3624 | 100.0% |
| IP Address | 3625 | 3624 | 100.0% |
| Have you been diagnosed with Alpha-gal Syndrome? | 3625 | 3625 | 100.0% |
| Question | N Total | N Answered | N Non-response | N Opt-out | Response Rate | Non-response Rate | Opt-out Rate | High Non-response? | High Opt-out? |
|---|---|---|---|---|---|---|---|---|---|
| Please provide any additional input, comments, opinions, or suggestions below. Please feel free to share advice or feedback for healthcare providers, other AGS patients, or other affected individuals. | 3625 | 1742 | 1883 | 450 | 48.1% | 51.9% | 12.4% | TRUE | TRUE |
| Besides avoidance of mammalian ingredients, are there other therapies or interventions you have discovered that help reduce the severity and frequency of Alpha-gal reactions or symptoms? Please Explain. | 3625 | 2303 | 1322 | 357 | 63.5% | 36.5% | 9.8% | TRUE | TRUE |
| Ethnicity: | 3625 | 2365 | 1260 | 0 | 65.2% | 34.8% | 0.0% | TRUE | FALSE |
| Education: | 3625 | 2375 | 1250 | 249 | 65.5% | 34.5% | 6.9% | TRUE | TRUE |
| Have you ever been diagnosed with any of the following tick-borne conditions? Please check all that apply. | 3625 | 2376 | 1249 | 6 | 65.5% | 34.5% | 0.2% | TRUE | FALSE |
| PREVENTION_METHOD | 3625 | 2386 | 1239 | 1443 | 65.8% | 34.2% | 39.8% | TRUE | TRUE |
| Race (Select all that apply): | 3625 | 2387 | 1238 | 56 | 65.8% | 34.2% | 1.5% | TRUE | FALSE |
| Household Income: | 3625 | 2390 | 1235 | 92 | 65.9% | 34.1% | 2.5% | TRUE | FALSE |
| When was your MOST RECENT AGS blood test performed and what was your Alpha-gal IgE value? | 3625 | 2405 | 1220 | 43 | 66.3% | 33.7% | 1.2% | TRUE | FALSE |
| Zip Code: | 3625 | 2408 | 1217 | 0 | 66.4% | 33.6% | 0.0% | TRUE | FALSE |
| Gender: | 3625 | 2429 | 1196 | 0 | 67.0% | 33.0% | 0.0% | TRUE | FALSE |
| Age Range: | 3625 | 2434 | 1191 | 0 | 67.1% | 32.9% | 0.0% | TRUE | FALSE |
| This concludes our survey. THANK YOU for your participation. Do you want to be contacted by TBC United with information about future clinical trials or research studies?: | 3625 | 2441 | 1184 | 86 | 67.3% | 32.7% | 2.4% | TRUE | FALSE |
| MENTAL_HEALTH_CONCERNS | 3625 | 2461 | 1164 | 0 | 67.9% | 32.1% | 0.0% | TRUE | FALSE |
| What, if any, financial impacts (positive or negative) have you experienced due to Alpha-gal Syndrome? | 3625 | 2466 | 1159 | 366 | 68.0% | 32.0% | 10.1% | TRUE | TRUE |
| What type of doctor or healthcare provider first made the Alpha-gal syndrome diagnosis? | 3625 | 2474 | 1151 | 0 | 68.2% | 31.8% | 0.0% | TRUE | FALSE |
| What, if any, social impacts (positive or negative) have you experienced due to Alpha-gal Syndrome (e.g. ability to go out, spend time with family and friends, etc)? | 3625 | 2522 | 1103 | 298 | 69.6% | 30.4% | 8.2% | TRUE | TRUE |
| Has the participant ever been diagnosed by a doctor as allergic to any of the following foods or food groups? (Check all that apply.) | 3625 | 2588 | 1037 | 283 | 71.4% | 28.6% | 7.8% | TRUE | TRUE |
| Choose the MOTOR (muscle) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3625 | 2591 | 1034 | 0 | 71.5% | 28.5% | 0.0% | TRUE | FALSE |
| Choose the NERVOUS SYSTEM (reflexes) symptoms that you experience after exposure to mammalian ingredients. (Select all that apply.) | 3625 | 2629 | 996 | 279 | 72.5% | 27.5% | 7.7% | TRUE | TRUE |
| Do you currently use products that have been genetically modified? | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to consume a food product such as steak, bacon, or lamb that is a product of animal biotechnology. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use OVER-THE-COUNTER MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use PRESCRIPTION MEDICATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use VACCINATIONS with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use FOOD PRODUCTS such as steak, bacon, or lamb that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use PERSONAL CARE PRODUCTS such as shampoo or cosmetics with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| Indicate your willingness to use HOUSEHOLD PRODUCTS such as cleaning products or laundry detergent with mammal ingredients that have had the alpha-gal carbohydrate removed and verified to be Alpha-gal free. | 3625 | 2634 | 991 | 0 | 72.7% | 27.3% | 0.0% | TRUE | FALSE |
| ACCESS_INFORMATION | 3625 | 2658 | 967 | 0 | 73.3% | 26.7% | 0.0% | TRUE | FALSE |
| When was your FIRST AGS blood test performed and what was your Alpha-gal IgE value? | 3625 | 2668 | 957 | 11 | 73.6% | 26.4% | 0.3% | TRUE | FALSE |
| Where have you had exposures that caused reactions to occur? Check all that apply. | 3625 | 2668 | 957 | 0 | 73.6% | 26.4% | 0.0% | TRUE | FALSE |
| Choose the CARDIOVASCULAR (heart) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2676 | 949 | 0 | 73.8% | 26.2% | 0.0% | TRUE | FALSE |
| At what age did you first begin experiencing allergic reactions (e.g. eczema, hives, itching) to mammalian ingredients? | 3625 | 2679 | 946 | 0 | 73.9% | 26.1% | 0.0% | TRUE | FALSE |
| What mammalian ingredients/items have you reacted to? Check all that apply. | 3625 | 2684 | 941 | 1267 | 74.0% | 26.0% | 35.0% | TRUE | TRUE |
| Choose the RESPIRATORY (lungs/breathing) symptoms you experience from a reaction to mammalian ingredients (Select all that apply.) | 3625 | 2685 | 940 | 1812 | 74.1% | 25.9% | 50.0% | TRUE | TRUE |
| How easy is it to identify Alpha-gal free vaccines? | 3625 | 2692 | 933 | 0 | 74.3% | 25.7% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free prescription medications? | 3625 | 2694 | 931 | 0 | 74.3% | 25.7% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free household items? Examples include cleaning products, laundry detergent, and dryer sheets. | 3625 | 2694 | 931 | 0 | 74.3% | 25.7% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free personal care products? Examples include shampoo, cosmetics, and soap. | 3625 | 2695 | 930 | 0 | 74.3% | 25.7% | 0.0% | TRUE | FALSE |
| Choose the SKIN symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2696 | 929 | 0 | 74.4% | 25.6% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free over-the-counter medications? | 3625 | 2696 | 929 | 0 | 74.4% | 25.6% | 0.0% | TRUE | FALSE |
| Would you use an Alpha-gal free valve replacement that was from a pig or other mammal that has been genetically modified? | 3625 | 2697 | 928 | 0 | 74.4% | 25.6% | 0.0% | TRUE | FALSE |
| Choose the GASTROINTESTINAL (digestive tract) symptoms you experience from a reaction to mammalian ingredients. (Select all that apply.) | 3625 | 2702 | 923 | 1933 | 74.5% | 25.5% | 53.3% | TRUE | TRUE |
| Choose the EMOTIONAL/BEHAVIORAL symptoms you experience due to the Alpha-gal Syndrome diagnosis (Select all that apply.) | 3625 | 2702 | 923 | 1051 | 74.5% | 25.5% | 29.0% | TRUE | TRUE |
| COMORBID_DIAGNOSIS | 3625 | 2704 | 921 | 724 | 74.6% | 25.4% | 20.0% | TRUE | TRUE |
| How many reactions did you experience prior to diagnosis? | 3625 | 2707 | 918 | 0 | 74.7% | 25.3% | 0.0% | TRUE | FALSE |
| How easy is it to identify Alpha-gal free food products? (Likeart scale 1-10) | 3625 | 2712 | 913 | 0 | 74.8% | 25.2% | 0.0% | TRUE | FALSE |
| If you needed a heart valve replacement and it were available, would you ask your healthcare provider to use an Alpha-gal free heart valve? | 3625 | 2714 | 911 | 0 | 74.9% | 25.1% | 0.0% | TRUE | FALSE |
| Would you eat Alpha-gal free pork, beef, or lamb? | 3625 | 2715 | 910 | 0 | 74.9% | 25.1% | 0.0% | TRUE | FALSE |
| What type of symptoms do you have? (Select all that apply.) | 3625 | 2718 | 907 | 2427 | 75.0% | 25.0% | 67.0% | TRUE | TRUE |
| Do you have other family members diagnosed with AGS? | 3625 | 2721 | 904 | 7 | 75.1% | 24.9% | 0.2% | TRUE | FALSE |
| Do you remember being bitten by a tick prior to symptoms of Alpha-gal Syndrome? | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| At what age were you diagnosed with Alpha-gal Syndrome? | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| Before you developed Alpha-gal Syndrome, what was your primary dietary preference? Please select the best option. | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| Since your Alpha-gal Syndrome diagnosis, how many reactions do you have per year? | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| Which of the following medical interventions have you experienced because of Alpha-gal Syndrome? | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| How soon after exposure to mammalian ingredients do your reactions occur? Check all that apply. | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 3625 | 2721 | 904 | 0 | 75.1% | 24.9% | 0.0% | TRUE | FALSE |
Count = number of those respondents who selected that specific category from AGS_SYMPTOMS
YearN = number of respondents in that year who gave a nonblank answer to AGS_SYMPTOMS
Total = Count of respondents across all years who selected that specific symptom category
| YEAR | AGS_SYMPTOMS | Count | YearN | Percentage | Total |
|---|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 398 | 470 | 84.7 | 2347 |
| 2020 | GASTROINTESTINAL | 397 | 490 | 81.0 | 2347 |
| 2021 | GASTROINTESTINAL | 190 | 236 | 80.5 | 2347 |
| 2022 | GASTROINTESTINAL | 540 | 623 | 86.7 | 2347 |
| 2023 | GASTROINTESTINAL | 548 | 612 | 89.5 | 2347 |
| 2024 | GASTROINTESTINAL | 274 | 286 | 95.8 | 2347 |
| 2019 | SKIN | 417 | 470 | 88.7 | 2274 |
| 2020 | SKIN | 428 | 490 | 87.3 | 2274 |
| 2021 | SKIN | 209 | 236 | 88.6 | 2274 |
| 2022 | SKIN | 527 | 623 | 84.6 | 2274 |
| 2023 | SKIN | 519 | 612 | 84.8 | 2274 |
| 2024 | SKIN | 174 | 286 | 60.8 | 2274 |
| 2019 | RESPIRATORY | 300 | 470 | 63.8 | 1631 |
| 2020 | RESPIRATORY | 321 | 490 | 65.5 | 1631 |
| 2021 | RESPIRATORY | 152 | 236 | 64.4 | 1631 |
| 2022 | RESPIRATORY | 354 | 623 | 56.8 | 1631 |
| 2023 | RESPIRATORY | 381 | 612 | 62.3 | 1631 |
| 2024 | RESPIRATORY | 123 | 286 | 43.0 | 1631 |
| 2019 | CARDIOVASCULAR | 185 | 470 | 39.4 | 1131 |
| 2020 | CARDIOVASCULAR | 211 | 490 | 43.1 | 1131 |
| 2021 | CARDIOVASCULAR | 100 | 236 | 42.4 | 1131 |
| 2022 | CARDIOVASCULAR | 254 | 623 | 40.8 | 1131 |
| 2023 | CARDIOVASCULAR | 285 | 612 | 46.6 | 1131 |
| 2024 | CARDIOVASCULAR | 96 | 286 | 33.6 | 1131 |
| 2019 | EMOTIONAL | 181 | 470 | 38.5 | 1047 |
| 2020 | EMOTIONAL | 170 | 490 | 34.7 | 1047 |
| 2021 | EMOTIONAL | 76 | 236 | 32.2 | 1047 |
| 2022 | EMOTIONAL | 249 | 623 | 40.0 | 1047 |
| 2023 | EMOTIONAL | 278 | 612 | 45.4 | 1047 |
| 2024 | EMOTIONAL | 93 | 286 | 32.5 | 1047 |
| 2019 | MOTOR (MUSCLES) | 108 | 470 | 23.0 | 651 |
| 2020 | MOTOR (MUSCLES) | 114 | 490 | 23.3 | 651 |
| 2021 | MOTOR (MUSCLES) | 52 | 236 | 22.0 | 651 |
| 2022 | MOTOR (MUSCLES) | 147 | 623 | 23.6 | 651 |
| 2023 | MOTOR (MUSCLES) | 170 | 612 | 27.8 | 651 |
| 2024 | MOTOR (MUSCLES) | 60 | 286 | 21.0 | 651 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 110 | 470 | 23.4 | 626 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 116 | 490 | 23.7 | 626 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 47 | 236 | 19.9 | 626 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 130 | 623 | 20.9 | 626 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 165 | 612 | 27.0 | 626 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 58 | 286 | 20.3 | 626 |
| 2019 | NOT SURE | 13 | 470 | 2.8 | 74 |
| 2020 | NOT SURE | 21 | 490 | 4.3 | 74 |
| 2021 | NOT SURE | 4 | 236 | 1.7 | 74 |
| 2022 | NOT SURE | 11 | 623 | 1.8 | 74 |
| 2023 | NOT SURE | 18 | 612 | 2.9 | 74 |
| 2024 | NOT SURE | 7 | 286 | 2.4 | 74 |
YearN = count of those answered records within each year (Denomenator)
Count= respondent answered yes, (numerator)
| YEAR | AGS_SYMPTOMS | Count | YearN | Percentage |
|---|---|---|---|---|
| 2019 | GASTROINTESTINAL | 398 | 470 | 84.7 |
| 2020 | GASTROINTESTINAL | 397 | 490 | 81.0 |
| 2021 | GASTROINTESTINAL | 190 | 236 | 80.5 |
| 2022 | GASTROINTESTINAL | 540 | 623 | 86.7 |
| 2023 | GASTROINTESTINAL | 548 | 612 | 89.5 |
| 2024 | GASTROINTESTINAL | 274 | 286 | 95.8 |
| 2019 | SKIN | 417 | 470 | 88.7 |
| 2020 | SKIN | 428 | 490 | 87.3 |
| 2021 | SKIN | 209 | 236 | 88.6 |
| 2022 | SKIN | 527 | 623 | 84.6 |
| 2023 | SKIN | 519 | 612 | 84.8 |
| 2024 | SKIN | 174 | 286 | 60.8 |
| 2019 | RESPIRATORY | 300 | 470 | 63.8 |
| 2020 | RESPIRATORY | 321 | 490 | 65.5 |
| 2021 | RESPIRATORY | 152 | 236 | 64.4 |
| 2022 | RESPIRATORY | 354 | 623 | 56.8 |
| 2023 | RESPIRATORY | 381 | 612 | 62.3 |
| 2024 | RESPIRATORY | 123 | 286 | 43.0 |
| 2019 | CARDIOVASCULAR | 185 | 470 | 39.4 |
| 2020 | CARDIOVASCULAR | 211 | 490 | 43.1 |
| 2021 | CARDIOVASCULAR | 100 | 236 | 42.4 |
| 2022 | CARDIOVASCULAR | 254 | 623 | 40.8 |
| 2023 | CARDIOVASCULAR | 285 | 612 | 46.6 |
| 2024 | CARDIOVASCULAR | 96 | 286 | 33.6 |
| 2019 | EMOTIONAL | 181 | 470 | 38.5 |
| 2020 | EMOTIONAL | 170 | 490 | 34.7 |
| 2021 | EMOTIONAL | 76 | 236 | 32.2 |
| 2022 | EMOTIONAL | 249 | 623 | 40.0 |
| 2023 | EMOTIONAL | 278 | 612 | 45.4 |
| 2024 | EMOTIONAL | 93 | 286 | 32.5 |
| 2019 | MOTOR (MUSCLES) | 108 | 470 | 23.0 |
| 2020 | MOTOR (MUSCLES) | 114 | 490 | 23.3 |
| 2021 | MOTOR (MUSCLES) | 52 | 236 | 22.0 |
| 2022 | MOTOR (MUSCLES) | 147 | 623 | 23.6 |
| 2023 | MOTOR (MUSCLES) | 170 | 612 | 27.8 |
| 2024 | MOTOR (MUSCLES) | 60 | 286 | 21.0 |
| 2019 | NERVOUS SYSTEM (REFLEXES) | 110 | 470 | 23.4 |
| 2020 | NERVOUS SYSTEM (REFLEXES) | 116 | 490 | 23.7 |
| 2021 | NERVOUS SYSTEM (REFLEXES) | 47 | 236 | 19.9 |
| 2022 | NERVOUS SYSTEM (REFLEXES) | 130 | 623 | 20.9 |
| 2023 | NERVOUS SYSTEM (REFLEXES) | 165 | 612 | 27.0 |
| 2024 | NERVOUS SYSTEM (REFLEXES) | 58 | 286 | 20.3 |
| 2019 | NOT SURE | 13 | 470 | 2.8 |
| 2020 | NOT SURE | 21 | 490 | 4.3 |
| 2021 | NOT SURE | 4 | 236 | 1.7 |
| 2022 | NOT SURE | 11 | 623 | 1.8 |
| 2023 | NOT SURE | 18 | 612 | 2.9 |
| 2024 | NOT SURE | 7 | 286 | 2.4 |
This code analyzes whether the major AGS symptom categories changed by year.
It uses the AGS_SYMPTOMS field, which contains the main
symptom categories each respondent selected. The code first identifies
respondents who answered that symptom question, then splits the
multi-select responses into individual categories such as Skin,
Gastrointestinal, and Respiratory.
For each category, the code creates a yes/no flag for whether that respondent selected it and runs a logistic regression by year. This tests whether the likelihood of selecting each symptom category was significantly different across survey years.
| Symptom | N | Events | LR_Stat | DF | P_Value | Converged | Note | P_Adjusted | Significant |
|---|---|---|---|---|---|---|---|---|---|
| SKIN | 2717 | 2274 | 105.381208 | 5 | 0.0000000 | TRUE | NA | 0.0000000 | TRUE |
| GASTROINTESTINAL | 2717 | 2347 | 52.324736 | 5 | 0.0000000 | TRUE | NA | 0.0000000 | TRUE |
| RESPIRATORY | 2717 | 1631 | 48.564233 | 5 | 0.0000000 | TRUE | NA | 0.0000000 | TRUE |
| EMOTIONAL | 2717 | 1047 | 24.234497 | 5 | 0.0001957 | TRUE | NA | 0.0009785 | TRUE |
| CARDIOVASCULAR | 2717 | 1131 | 15.575663 | 5 | 0.0081660 | TRUE | NA | 0.0326641 | TRUE |
| NERVOUS SYSTEM (REFLEXES) | 2717 | 626 | 9.566549 | 5 | 0.0884909 | TRUE | NA | 0.2654726 | FALSE |
| NOT SURE | 2717 | 74 | 7.595189 | 5 | 0.1800020 | TRUE | NA | 0.3600041 | FALSE |
| MOTOR (MUSCLES) | 2717 | 651 | 7.087258 | 5 | 0.2142313 | TRUE | NA | 0.3600041 | FALSE |
The reference year used in the logistic regression is 2019, so each odds ratio compares a given year against 2019.
ex: Compared with the reference year(2019), the odds of reporting gastrointestinal symptoms were significantly higher in 2023 (OR = 1.55, 95% CI: 1.08 to 2.23, p = 0.017), indicating approximately 55% higher odds of selecting gastrointestinal symptoms.
| Symptom | Term | OR | CI_Lower | CI_Upper | P_Value |
|---|---|---|---|---|---|
| SKIN | YEAR2020 | 0.8773884 | 0.5922122 | 1.2958671 | 0.5116686 |
| SKIN | YEAR2021 | 0.9838352 | 0.6063867 | 1.6292088 | 0.9482660 |
| SKIN | YEAR2022 | 0.6977168 | 0.4845709 | 0.9952115 | 0.0495014 |
| SKIN | YEAR2023 | 0.7092906 | 0.4917362 | 1.0138873 | 0.0622720 |
| SKIN | YEAR2024 | 0.1974563 | 0.1353630 | 0.2849201 | 0.0000000 |
| GASTROINTESTINAL | YEAR2020 | 0.7722483 | 0.5497903 | 1.0810867 | 0.1335224 |
| GASTROINTESTINAL | YEAR2021 | 0.7472143 | 0.4982081 | 1.1293160 | 0.1618970 |
| GASTROINTESTINAL | YEAR2022 | 1.1769692 | 0.8355078 | 1.6548226 | 0.3492434 |
| GASTROINTESTINAL | YEAR2023 | 1.5489950 | 1.0804459 | 2.2253178 | 0.0173851 |
| GASTROINTESTINAL | YEAR2024 | 4.1306529 | 2.2819022 | 8.1363963 | 0.0000102 |
| CARDIOVASCULAR | YEAR2020 | 1.1650683 | 0.9008870 | 1.5075381 | 0.2445625 |
| CARDIOVASCULAR | YEAR2021 | 1.1327504 | 0.8236979 | 1.5555420 | 0.4418354 |
| CARDIOVASCULAR | YEAR2022 | 1.0604263 | 0.8306447 | 1.3547512 | 0.6381201 |
| CARDIOVASCULAR | YEAR2023 | 1.3426729 | 1.0526280 | 1.7146205 | 0.0178733 |
| CARDIOVASCULAR | YEAR2024 | 0.7783784 | 0.5713186 | 1.0569428 | 0.1101330 |
| EMOTIONAL | YEAR2020 | 0.8482390 | 0.6519195 | 1.1031835 | 0.2197995 |
| EMOTIONAL | YEAR2021 | 0.7584254 | 0.5435103 | 1.0527941 | 0.1007988 |
| EMOTIONAL | YEAR2022 | 1.0630337 | 0.8319685 | 1.3593396 | 0.6253837 |
| EMOTIONAL | YEAR2023 | 1.3289774 | 1.0411325 | 1.6984436 | 0.0226766 |
| EMOTIONAL | YEAR2024 | 0.7693871 | 0.5634910 | 1.0467144 | 0.0967654 |
| RESPIRATORY | YEAR2020 | 1.0763314 | 0.8259154 | 1.4028520 | 0.5860756 |
| RESPIRATORY | YEAR2021 | 1.0253968 | 0.7410689 | 1.4237667 | 0.8802196 |
| RESPIRATORY | YEAR2022 | 0.7457249 | 0.5826025 | 0.9531474 | 0.0194256 |
| RESPIRATORY | YEAR2023 | 0.9346320 | 0.7280437 | 1.1987318 | 0.5949772 |
| RESPIRATORY | YEAR2024 | 0.4276074 | 0.3161728 | 0.5766774 | 0.0000000 |
| MOTOR (MUSCLES) | YEAR2020 | 1.0162530 | 0.7527108 | 1.3726872 | 0.9161574 |
| MOTOR (MUSCLES) | YEAR2021 | 0.9472625 | 0.6473884 | 1.3733310 | 0.7772828 |
| MOTOR (MUSCLES) | YEAR2022 | 1.0351307 | 0.7802765 | 1.3762882 | 0.8113466 |
| MOTOR (MUSCLES) | YEAR2023 | 1.2891738 | 0.9772721 | 1.7059008 | 0.0736737 |
| MOTOR (MUSCLES) | YEAR2024 | 0.8898722 | 0.6204273 | 1.2674222 | 0.5213990 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2020 | 1.0150705 | 0.7532348 | 1.3685142 | 0.9217079 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2021 | 0.8138528 | 0.5505703 | 1.1890088 | 0.2934333 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2022 | 0.8629910 | 0.6472737 | 1.1519646 | 0.3159362 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2023 | 1.2080537 | 0.9156218 | 1.5982796 | 0.1831953 |
| NERVOUS SYSTEM (REFLEXES) | YEAR2024 | 0.8325359 | 0.5790150 | 1.1877467 | 0.3166240 |
| NOT SURE | YEAR2020 | 1.5740528 | 0.7879790 | 3.2620769 | 0.2063186 |
| NOT SURE | YEAR2021 | 0.6061008 | 0.1692517 | 1.7344899 | 0.3857983 |
| NOT SURE | YEAR2022 | 0.6318502 | 0.2751030 | 1.4255562 | 0.2677767 |
| NOT SURE | YEAR2023 | 1.0652681 | 0.5197539 | 2.2430032 | 0.8640452 |
| NOT SURE | YEAR2024 | 0.8819961 | 0.3280039 | 2.1802649 | 0.7914734 |
| Symptom | Contrast | OddsRatio | CI_Lower | CI_Upper | P_Value |
|---|---|---|---|---|---|
| SKIN | YEAR2019 / YEAR2020 | 1.1397461 | 0.6349216 | 2.0459550 | 1.0000000 |
| SKIN | YEAR2019 / YEAR2021 | 1.0164304 | 0.4862987 | 2.1244779 | 1.0000000 |
| SKIN | YEAR2019 / YEAR2022 | 1.4332462 | 0.8370062 | 2.4542167 | 0.4950138 |
| SKIN | YEAR2019 / YEAR2023 | 1.4098593 | 0.8209498 | 2.4212238 | 0.5604478 |
| SKIN | YEAR2019 / YEAR2024 | 5.0644112 | 2.9031042 | 8.8347711 | 0.0000000 |
| SKIN | YEAR2020 / YEAR2021 | 0.8918043 | 0.4337909 | 1.8334060 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2022 | 1.2575136 | 0.7513993 | 2.1045275 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2023 | 1.2369942 | 0.7368900 | 2.0765035 | 1.0000000 |
| SKIN | YEAR2020 / YEAR2024 | 4.4434557 | 2.6041036 | 7.5819943 | 0.0000000 |
| SKIN | YEAR2021 / YEAR2022 | 1.4100780 | 0.7122808 | 2.7914833 | 1.0000000 |
| SKIN | YEAR2021 / YEAR2023 | 1.3870691 | 0.6990485 | 2.7522567 | 1.0000000 |
| SKIN | YEAR2021 / YEAR2024 | 4.9825458 | 2.4800440 | 10.0102105 | 0.0000000 |
| SKIN | YEAR2022 / YEAR2023 | 0.9836826 | 0.6184808 | 1.5645293 | 1.0000000 |
| SKIN | YEAR2022 / YEAR2024 | 3.5335249 | 2.1816548 | 5.7230860 | 0.0000000 |
| SKIN | YEAR2023 / YEAR2024 | 3.5921394 | 2.2106435 | 5.8369726 | 0.0000000 |
| GASTROINTESTINAL | YEAR2019 / YEAR2020 | 1.2949202 | 0.7810124 | 2.1469806 | 0.6042020 |
| GASTROINTESTINAL | YEAR2019 / YEAR2021 | 1.3383041 | 0.7260739 | 2.4667707 | 0.6042020 |
| GASTROINTESTINAL | YEAR2019 / YEAR2022 | 0.8496399 | 0.5097258 | 1.4162281 | 0.6984867 |
| GASTROINTESTINAL | YEAR2019 / YEAR2023 | 0.6455799 | 0.3761959 | 1.1078627 | 0.1216954 |
| GASTROINTESTINAL | YEAR2019 / YEAR2024 | 0.2420925 | 0.0942267 | 0.6219971 | 0.0001330 |
| GASTROINTESTINAL | YEAR2020 / YEAR2021 | 1.0335031 | 0.5734457 | 1.8626500 | 0.8695663 |
| GASTROINTESTINAL | YEAR2020 / YEAR2022 | 0.6561330 | 0.4044510 | 1.0644319 | 0.0846100 |
| GASTROINTESTINAL | YEAR2020 / YEAR2023 | 0.4985480 | 0.2980413 | 0.8339451 | 0.0008581 |
| GASTROINTESTINAL | YEAR2020 / YEAR2024 | 0.1869555 | 0.0738217 | 0.4734699 | 0.0000018 |
| GASTROINTESTINAL | YEAR2021 / YEAR2022 | 0.6348631 | 0.3506488 | 1.1494441 | 0.1480199 |
| GASTROINTESTINAL | YEAR2021 / YEAR2023 | 0.4823865 | 0.2597963 | 0.8956892 | 0.0054481 |
| GASTROINTESTINAL | YEAR2021 / YEAR2024 | 0.1808950 | 0.0671607 | 0.4872342 | 0.0000057 |
| GASTROINTESTINAL | YEAR2022 / YEAR2023 | 0.7598276 | 0.4518672 | 1.2776719 | 0.6042020 |
| GASTROINTESTINAL | YEAR2022 / YEAR2024 | 0.2849354 | 0.1121835 | 0.7237087 | 0.0008581 |
| GASTROINTESTINAL | YEAR2023 / YEAR2024 | 0.3750000 | 0.1452617 | 0.9680809 | 0.0216053 |
| CARDIOVASCULAR | YEAR2019 / YEAR2020 | 0.8583188 | 0.5838275 | 1.2618643 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2021 | 0.8828070 | 0.5486139 | 1.4205769 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2022 | 0.9430170 | 0.6538867 | 1.3599926 | 1.0000000 |
| CARDIOVASCULAR | YEAR2019 / YEAR2023 | 0.7447830 | 0.5169194 | 1.0730914 | 0.2323526 |
| CARDIOVASCULAR | YEAR2019 / YEAR2024 | 1.2847222 | 0.8107712 | 2.0357298 | 0.9911967 |
| CARDIOVASCULAR | YEAR2020 / YEAR2021 | 1.0285305 | 0.6426197 | 1.6461911 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2022 | 1.0986792 | 0.7671861 | 1.5734070 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2023 | 0.8677231 | 0.6064976 | 1.2414613 | 1.0000000 |
| CARDIOVASCULAR | YEAR2020 / YEAR2024 | 1.4967891 | 0.9498711 | 2.3586123 | 0.1292823 |
| CARDIOVASCULAR | YEAR2021 / YEAR2022 | 1.0682029 | 0.6779097 | 1.6831998 | 1.0000000 |
| CARDIOVASCULAR | YEAR2021 / YEAR2023 | 0.8436533 | 0.5358116 | 1.3283601 | 1.0000000 |
| CARDIOVASCULAR | YEAR2021 / YEAR2024 | 1.4552696 | 0.8536117 | 2.4809989 | 0.4621015 |
| CARDIOVASCULAR | YEAR2022 / YEAR2023 | 0.7897875 | 0.5636072 | 1.1067358 | 0.4621015 |
| CARDIOVASCULAR | YEAR2022 / YEAR2024 | 1.3623532 | 0.8786496 | 2.1123395 | 0.4621015 |
| CARDIOVASCULAR | YEAR2023 / YEAR2024 | 1.7249618 | 1.1133910 | 2.6724602 | 0.0038527 |
| EMOTIONAL | YEAR2019 / YEAR2020 | 1.1789131 | 0.7952311 | 1.7477134 | 1.0000000 |
| EMOTIONAL | YEAR2019 / YEAR2021 | 1.3185212 | 0.8040640 | 2.1621391 | 0.6773578 |
| EMOTIONAL | YEAR2019 / YEAR2022 | 0.9407040 | 0.6514123 | 1.3584698 | 1.0000000 |
| EMOTIONAL | YEAR2019 / YEAR2023 | 0.7524582 | 0.5216615 | 1.0853655 | 0.2721194 |
| EMOTIONAL | YEAR2019 / YEAR2024 | 1.2997358 | 0.8177626 | 2.0657746 | 0.6773578 |
| EMOTIONAL | YEAR2020 / YEAR2021 | 1.1184211 | 0.6819061 | 1.8343665 | 1.0000000 |
| EMOTIONAL | YEAR2020 / YEAR2022 | 0.7979418 | 0.5524091 | 1.1526079 | 0.5728682 |
| EMOTIONAL | YEAR2020 / YEAR2023 | 0.6382644 | 0.4423777 | 0.9208905 | 0.0045402 |
| EMOTIONAL | YEAR2020 / YEAR2024 | 1.1024866 | 0.6935144 | 1.7526334 | 1.0000000 |
| EMOTIONAL | YEAR2021 / YEAR2022 | 0.7134538 | 0.4440522 | 1.1462984 | 0.3661651 |
| EMOTIONAL | YEAR2021 / YEAR2023 | 0.5706835 | 0.3555113 | 0.9160880 | 0.0065489 |
| EMOTIONAL | YEAR2021 / YEAR2024 | 0.9857527 | 0.5677064 | 1.7116391 | 1.0000000 |
| EMOTIONAL | YEAR2022 / YEAR2023 | 0.7998884 | 0.5703273 | 1.1218496 | 0.4741648 |
| EMOTIONAL | YEAR2022 / YEAR2024 | 1.3816629 | 0.8885160 | 2.1485177 | 0.3476796 |
| EMOTIONAL | YEAR2023 / YEAR2024 | 1.7273196 | 1.1118717 | 2.6834327 | 0.0040616 |
| RESPIRATORY | YEAR2019 / YEAR2020 | 0.9290819 | 0.6249639 | 1.3811889 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2021 | 0.9752322 | 0.5983443 | 1.5895159 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2022 | 1.3409771 | 0.9276880 | 1.9383883 | 0.1748308 |
| RESPIRATORY | YEAR2019 / YEAR2023 | 1.0699398 | 0.7366561 | 1.5540102 | 1.0000000 |
| RESPIRATORY | YEAR2019 / YEAR2024 | 2.3385940 | 1.4914917 | 3.6668133 | 0.0000004 |
| RESPIRATORY | YEAR2020 / YEAR2021 | 1.0496730 | 0.6450601 | 1.7080787 | 1.0000000 |
| RESPIRATORY | YEAR2020 / YEAR2022 | 1.4433357 | 1.0006476 | 2.0818697 | 0.0327803 |
| RESPIRATORY | YEAR2020 / YEAR2023 | 1.1516097 | 0.7945697 | 1.6690858 | 1.0000000 |
| RESPIRATORY | YEAR2020 / YEAR2024 | 2.5171020 | 1.6081650 | 3.9397714 | 0.0000000 |
| RESPIRATORY | YEAR2021 / YEAR2022 | 1.3750336 | 0.8642794 | 2.1876230 | 0.3527615 |
| RESPIRATORY | YEAR2021 / YEAR2023 | 1.0971129 | 0.6869760 | 1.7521086 | 1.0000000 |
| RESPIRATORY | YEAR2021 / YEAR2024 | 2.3979868 | 1.4098139 | 4.0787942 | 0.0000161 |
| RESPIRATORY | YEAR2022 / YEAR2023 | 0.7978807 | 0.5673465 | 1.1220897 | 0.3635796 |
| RESPIRATORY | YEAR2022 / YEAR2024 | 1.7439478 | 1.1419711 | 2.6632494 | 0.0012703 |
| RESPIRATORY | YEAR2023 / YEAR2024 | 2.1857248 | 1.4253071 | 3.3518342 | 0.0000010 |
| Question | RespondentCount |
|---|---|
| ADDITIONAL_ALLERGIES | 2720 |
| AGE_AT_DIAGNOSIS | 2720 |
| DIAGNOSED_WITH_ALPHA_GAL_SYNDROME | 2720 |
| EXPOSED | 2720 |
| MEDICAL_INTERVENTIONS_FOR_ALPHA_GAL_SYNDROME | 2720 |
| OTHER_FAMILY_MEMBERS_DIAGNOSED_WITH_AGS | 2720 |
| OUTGROWN_OR_TOLERANT_TO_MAMMALIAN_INGREDIENTS | 2720 |
| POST_EXPOSURE_TIME | 2720 |
| PRIMARY_DIETARY_PREFERENCE_PREDIAGNOSIS | 2720 |
| RESPONDENT_ID | 2720 |
| START_DATE | 2720 |
| YEAR | 2720 |
| AGS_SYMPTOMS | 2717 |
| WOULD_YOU_EAT_ALPHA_GAL_FREE_PORK_BEEF_OR_LAMB | 2714 |
| WILLINGNESS_TO_USE_HEART_VALVE | 2713 |
| HOW_EASY_IS_IT_TO_IDENTIFY_ALPHA_GAL_FREE_FOOD_PRODUCTS_LIKEART_SCALE_1_10 | 2711 |
| COMORBID_DIAGNOSIS | 2703 |
| EMOTIONAL_BEHAVIORAL | 2701 |
| GASTROINTESTINAL | 2701 |
| WOULD_YOU_USE_AN_ALPHA_GAL_FREE_VALVE_REPLACEMENT_THAT_WAS_FROM_A_PIG_OR_OTHER_MAMMAL_THAT_HAS_BEEN_GENETICALLY_MODIFIED | 2696 |
| EASE_OF_IDENTIFYING_OTC_MEDICATIONS | 2695 |
| SKIN | 2695 |
| HOW_EASY_IS_IT_TO_IDENTIFY_ALPHA_GAL_FREE_PERSONAL_CARE_PRODUCTS_EXAMPLES_INCLUDE_SHAMPOO_COSMETICS_AND_SOAP | 2694 |
| EASE_OF_IDENTIFYING_RX_MEDICATIONS | 2693 |
| HOW_EASY_IS_IT_TO_IDENTIFY_ALPHA_GAL_FREE_HOUSEHOLD_ITEMS_EXAMPLES_INCLUDE_CLEANING_PRODUCTS_LAUNDRY_DETERGENT_AND_DRYER_SHEETS | 2693 |
| EASE_OF_IDENTIFYING_VACCINES | 2691 |
| RESPIRATORY | 2684 |
| MAMMAL_INGREDIENT_REACTION | 2683 |
| AGE_AT_FIRST_ALLERGIC_REACTIONS | 2678 |
| CARDIOVASCULAR | 2675 |
| ACCESS_INFORMATION | 2657 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_FOOD_PRODUCTS_SUCH_AS_STEAK_BACON_OR_LAMB_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_HOUSEHOLD_PRODUCTS_SUCH_AS_CLEANING_PRODUCTS_OR_LAUNDRY_DETERGENT_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_OVER_THE_COUNTER_MEDICATIONS_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_PERSONAL_CARE_PRODUCTS_SUCH_AS_SHAMPOO_OR_COSMETICS_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_PRESCRIPTION_MEDICATIONS_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| INDICATE_YOUR_WILLINGNESS_TO_USE_VACCINATIONS_WITH_MAMMAL_INGREDIENTS_THAT_HAVE_HAD_THE_ALPHA_GAL_CARBOHYDRATE_REMOVED_AND_VERIFIED_TO_BE_ALPHA_GAL_FREE | 2633 |
| USE_OF_GMO_PRODUCTS | 2633 |
| WILLINGNESS_TO_CONSUME_MODIFIED_MEAT_PRODUCTS | 2633 |
| NERVOUS_SYSTEM | 2628 |
| MOTOR | 2590 |
| NUMBER_REACTIONS_PRIOR_TO_DIAGNOSIS | 2567 |
| WHAT_IF_ANY_SOCIAL_IMPACTS_POSITIVE_OR_NEGATIVE_HAVE_YOU_EXPERIENCED_DUE_TO_ALPHA_GAL_SYNDROME_E_G_ABILITY_TO_GO_OUT_SPEND_TIME_WITH_FAMILY_AND_FRIENDS_ETC | 2521 |
| TYPE_OF_HEALTHCARE_PROVIDER_DIAGNOSIS | 2473 |
| FINANCIAL_IMPACTS_OF_AGS | 2465 |
| MENTAL_HEALTH_CONCERNS | 2460 |
| THIS_CONCLUDES_OUR_SURVEY_THANK_YOU_FOR_YOUR_PARTICIPATION_DO_YOU_WANT_TO_BE_CONTACTED_BY_TBC_UNITED_WITH_INFORMATION_ABOUT_FUTURE_CLINICAL_TRIALS_OR_RESEARCH_STUDIES | 2440 |
| AGE_RANGE | 2433 |
| GENDER | 2428 |
| ZIP_CODE | 2407 |
| HOUSEHOLD_INCOME | 2389 |
| RACE | 2386 |
| PREVENTION_METHOD | 2385 |
| ADDITIONAL_TB_DIAGNOSIS | 2375 |
| EDUCATION | 2374 |
| ETHNICITY | 2364 |
| OTHER_THERAPIES_TO_REDUCES_REACTIONS | 2302 |
| IGE_LEVEL_FIRST_AGS_BLOOD_TEST_CLEAN | 1888 |
| ADDITIONAL_COMMENTS | 1741 |
| DATE_RECENT_AGS_BLOOD_TEST_OTHER | 1028 |
| X287 | 741 |
| MEDICAL_INTERVENTIONS_FOR_ALPHA_GAL_SYNDROME_OTHER | 591 |
| EXPOSED_OTHER | 570 |
| ADDITIONAL_TB_DIAGNOSIS_OTHER | 444 |
| ADDITIONAL_ALLERGIES_OTHER | 426 |
| OUTGROWN_OR_TOLERANT_COMMENTS | 418 |
| MENTAL_HEALTH_CONCERNS_OTHER | 391 |
| X281 | 362 |
| GASTROINTESTINAL_OTHER | 283 |
| SKIN_OTHER | 275 |
| TYPE_OF_HEALTHCARE_PROVIDER_DIAGNOSIS_OTHER | 247 |
| X261 | 237 |
| CARDIOVASCULAR_OTHER | 232 |
| X300 | 184 |
| EMOTIONAL_BEHAVIORAL_OTHER | 177 |
| NERVOUS_SYSTEM_OTHER | 173 |
| RESPIRATORY_OTHER | 157 |
| DATE_RECENT_AGS_BLOOD_TEST | 17 |
| DATE_FIRST_AGS_BLOOD_TEST | 0 |
| IGE_LEVEL_FIRST_AGS_BLOOD_TEST | 0 |
| MOTOR_OTHER | 0 |
| REACTIONS_PER_YEAR_POST_DIAGNOSIS | 0 |
| X61 | 0 |
START_DATE ranges from 2019-12-14 to 2024-12-27